| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Original Articles |
The calf muscle energy metabolism of 8 stable chronic obstructive pulmonary disease (COPD) patients with chronic respiratory failure (arterial oxygen tension (Pao2) 7.7 +/- 0.4 kPa or 58 +/- 3 mmHg) was studied, using 31-phosphorus magnetic resonance spectroscopy (31P MRS). MRS spectra were acquired at rest and during the course of 360 pedal movements at 20, 35 and 50% of the maximal voluntary contraction (MVC) and during recovery. Eight healthy age-matched subjects served as the control group. No significant differences between groups were observed in resting muscle, as regards intracellular pH, Pi/PCr ratio (Pi: inorganic phosphate; PCr: phosphocreatine) and the relative ATP expressed as the ratio beta ATP/PCr + Pi + PME (PME: phosphomonoester). Although effective power outputs were similar for both groups at each work level, COPD patients exhibited a higher Pi/PCr ratio than health controls (3.34 +/- 0.89 vs 0.49 +/- 0.05 at 50% MVC; p less than 0.01) and a lower pHi (6.65 +/- 0.11 vs 7.06 +/- 0.02 at 50% MVC; p less than 0.01). PCr resynthesis during recovery was slower in patients than in control subjects (t1/2 PCr 1.27 +/- 0.26 min vs 0.47 +/- 0.05 min; p less than 0.05). These results suggest impairment of aerobic capacity in a non-ventilatory working muscle, which may be due to hypoxaemia in patients with chronic respiratory failure.
This article has been cited by other articles:
|
|
 |
|
  R. Debigare and F. Maltais The major limitation to exercise performance in COPD is lower limb muscle dysfunction J Appl Physiol, August 1, 2008; 105(2): 751 - 753. [Full Text] [PDF]
|
|
|
|
|
|
G. R. Chiappa, A. Borghi-Silva, L. F. Ferreira, C. Carrascosa, C. C. Oliveira, J. Maia, A. C. Gimenes, F. Queiroga Jr, D. Berton, E. M. V. Ferreira, et al. Kinetics of muscle deoxygenation are accelerated at the onset of heavy-intensity exercise in patients with COPD: relationship to central cardiovascular dynamics J Appl Physiol, May 1, 2008; 104(5): 1341 - 1350. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Jelic and T. H. Le Jemtel Diagnostic Usefulness of B-Type Natriuretic Peptide and Functional Consequences of Muscle Alterations in COPD and Chronic Heart Failure. Chest, October 1, 2006; 130(4): 1220 - 1230. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Barreiro, J. Gea, G. Matar, and S. N.A. Hussain Expression and Carbonylation of Creatine Kinase in the Quadriceps Femoris Muscles of Patients with Chronic Obstructive Pulmonary Disease Am. J. Respir. Cell Mol. Biol., December 1, 2005; 33(6): 636 - 642. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. P Mattson and J. C Martin Emphysema-induced reductions in locomotory skeletal muscle contractile function Exp Physiol, July 1, 2005; 90(4): 519 - 525. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Saey, A. Michaud, A. Couillard, C. H. Cote, M. J. Mador, P. LeBlanc, J. Jobin, and F. Maltais Contractile Fatigue, Muscle Morphometry, and Blood Lactate in Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., May 15, 2005; 171(10): 1109 - 1115. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R.T. Jagoe and M.P.K.J. Engelen Muscle wasting and changes in muscle protein metabolism in chronic obstructive pulmonary disease Eur. Respir. J., November 2, 2003; 22(46_suppl): 52s - 63s. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A.G.N. Agusti, A. Noguera, J. Sauleda, E. Sala, J. Pons, and X. Busquets Systemic effects of chronic obstructive pulmonary disease Eur. Respir. J., February 1, 2003; 21(2): 347 - 360. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Haccoun, A. A. Smountas, W. J. Gibbons, J. Bourbeau, and L. C. Lands Isokinetic Muscle Function in COPD* Chest, April 1, 2002; 121(4): 1079 - 1084. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.G. Gea, M. Pasto, M.A. Carmona, M. Orozco-Levi, J. Palomeque, and J. Broquetas Metabolic characteristics of the deltoid muscle in patients with chronic obstructive pulmonary disease Eur. Respir. J., May 1, 2001; 17(5): 939 - 945. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. R Gosker, E. F. Wouters, G. J van der Vusse, and A. M. Schols Skeletal muscle dysfunction in chronic obstructive pulmonary disease and chronic heart failure: underlying mechanisms and therapy perspectives Am. J. Clinical Nutrition, May 1, 2000; 71(5): 1033 - 1047. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. F.M. Wouters Nutrition and Metabolism in COPD Chest, May 1, 2000; 117(5_suppl_1): 274S - 280S. [Full Text] [PDF]
|
|
|
|
|
|
Skeletal Muscle Dysfunction in Chronic Obstructive Pulmonary Disease . A Statement of the American Thoracic Society and European Respiratory Society Am. J. Respir. Crit. Care Med., April 1, 1999; 159(4): S2 - 40. [Full Text] [PDF]
|
|
|
|
|
|
J. P. Mattson and D. C. Poole Pulmonary emphysema decreases hamster skeletal muscle oxidative enzyme capacity J Appl Physiol, July 1, 1998; 85(1): 210 - 214. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. SAULEDA, F. GARCÍA-PALMER, R. J. WIESNER, S. TARRAGA, I. HARTING, P. TOMÁS, C. GÓMEZ, C. SAUS, A. PALOU, and A. G. N. AGUSTÍ Cytochrome Oxidase Activity and Mitochondrial Gene Expression in Skeletal Muscle of Patients with Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., May 1, 1997; 157(5): 1413 - 1417. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
